MeSH term
Frequency | Condition_Probility | Animals | 19 | 0.0 |
Humans | 33 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Cell Differentiation/*physiology | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 6 | 1.0 |
Cell Cycle/*physiology | 3 | 1.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 6 | 0.0 |
Phosphorylation | 14 | 0.0 |
*Protein-Serine-Threonine Kinases | 5 | 0.0 |
Proto-Oncogene Proteins/metabolism | 7 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Transcription Factors/*metabolism | 7 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cells, Cultured | 8 | 0.0 |
Immunoblotting | 3 | 0.0 |
Mice | 9 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 4 | 1.0 |
Cell Line | 6 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Signal Transduction | 10 | 0.0 |
Cell Cycle Proteins/genetics/metabolism | 2 | 2.0 |
Gene Deletion | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Time Factors | 5 | 0.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Tumor Suppressor Proteins/genetics/metabolism | 2 | 6.0 |
Up-Regulation | 4 | 0.0 |
Binding Sites | 7 | 0.0 |
Promoter Regions (Genetics) | 9 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 3 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 3 | 1.0 |
Cell Cycle | 2 | 0.0 |
Cell Cycle Proteins/metabolism | 2 | 0.0 |
Cell Division | 4 | 0.0 |
Cell Survival | 4 | 0.0 |
Down-Regulation | 4 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Tumor Suppressor Proteins/metabolism | 2 | 1.0 |
Apoptosis | 4 | 0.0 |
Base Sequence | 5 | 0.0 |
Mutation | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 6 | 0.0 |
Enzyme Activation | 4 | 0.0 |
Enzyme Inhibitors/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Female | 7 | 0.0 |
Rats | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
*Proto-Oncogene Proteins | 3 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Transfection | 3 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Cyclins/*genetics/metabolism | 2 | 4.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
3T3 Cells | 2 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Blotting, Western | 5 | 0.0 |
Endothelium, Vascular/cytology | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Umbilical Veins/cytology | 3 | 1.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Male | 3 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
